INDV · Indivior Pharmaceuticals, Inc. · Proposed Sales
$36.00
+0.15 (+0.42%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$4.23B
Shares
118.01M
Volume · Sep 30
1.67M
Avg daily vol (3M)
2.03M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-07-10 | Heidbreder Christian | Officer | 18,586 | 2026-07-10 | Fidelity Brokerage Services LLC |
| 2026-06-11 | Heidbreder Christian | Officer | 18,586 | 2026-06-11 | Fidelity Brokerage Services LLC |
| 2026-06-08 | Preblick Ryan | Officer | 36,000 | 2026-06-08 | Fidelity Brokerage Services LLC |
| 2025-11-07 | Cetani Cynthia C | Officer | 121,737 | 2025-11-07 | Stifel Nicolaus & Company Inc |
| 2025-09-08 | Crossley Mark | Affiliate | 26,463 | 2025-09-08 | Merrill Lynch, Pierce, Fenner & Smith Inc. |
| 2025-09-08 | Mark Crossley | affiliate | 183,938 | 2025-09-08 | J.P. Morgan Securities LLC |
| 2025-09-04 | Mark Crossley | affiliate | 30,000 | 2025-09-04 | J.P. Morgan Securities LLC |
| 2025-08-28 | Mark Crossley | affiliate | 52,320 | 2025-08-28 | J.P. Morgan Securities LLC |
| 2024-03-20 | Heidbreder Christian | Officer | 6,284 | 2024-03-13 | Global Shares Execution Services Limited |
| 2024-03-14 | Cetani Cynthia C | Officer | 66,073 | 2024-03-14 | Stifel Nicolaus & Company Inc. |
Showing 1–10 of 10 filings